Co-monitoring serum anodal trypsinogen, serum amylase, and serum creatinine accurately differentiates rejection from other causes of allograft dysfunction after simultaneous pancreas-kidney transplantation

Transplantation Proceedings

Volumn 29, Issue 1-2, 1997, Pages 676-677

  Lieberman, J M ^a   Marks, W H ^a   Stuart, F P ^a   Abecassis, M M ^a   Florence, L S ^a   Kauffman, D ^a  

^a SWEDISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; CREATININE; TRYPSINOGEN;

AMYLASE BLOOD LEVEL; BIOPSY; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; GRAFT FAILURE; GRAFT REJECTION; HUMAN; HUMAN TISSUE; KIDNEY TRANSPLANTATION; PANCREAS TRANSPLANTATION; PANCREATITIS; PATIENT MONITORING; PRIORITY JOURNAL;

ACUTE DISEASE; AMYLASES; BIOLOGICAL MARKERS; CREATININE; DIAGNOSIS, DIFFERENTIAL; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MONITORING, PHYSIOLOGIC; PANCREAS TRANSPLANTATION; PANCREATITIS; POSTOPERATIVE COMPLICATIONS; TRANSPLANTATION, HOMOLOGOUS; TRYPSINOGEN;

EID: 0030908923     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(96)00397-1     Document Type: Conference Paper

References (0)